About Deng Mao
Deng Mao is a director at TECLens.
Form D filings also name Deng Mao as a director at CSA Medical.
Deng Mao first appears on SEC filings in 2024.
Experience
This experience comes from Deng Mao's profile and from SEC filings. For roles taken from filings, the years are when the filings name Deng Mao in the role, so the role may have started earlier or lasted longer.
TECLens, Inc. Current
Interim Chief Executive Officer (2024 – Present)
Director
2024 – Present · Stamford, CT
Develops a vision correction device for people with refractive errors.
CSA Medical, Inc. Current
Director
2024 – Present · Lexington, MA
Develops a liquid nitrogen treatment device for people with chronic bronchitis.
EN
Evasc Neurovascular Current
Board Member
2024 – Present
AI
ARC Medical Inc. Current
Board Member
2023 – Present
ZE
Zeto / Rapid Full-Montage EEG Current
Board Observer
2023 – Present
YV
Yonjin Venture Current
Investment Manager
2021 – Present
ZM
Ziteo Medical
Board Member
2024 – 2025
CA
Cardionomic
Board Member
2023 – 2024
PH
Philips
Clinical Scientist
2017 – 2021
JM
Johns Hopkins Medicine
Graduate Research Student
2015 – 2017
UC
UT Southwestern Medical Center
Graduate Research Student
2010 – 2014
Key Colleagues at Startups
The people Deng Mao works with at each company, as listed on that company's latest Form D.
TECLens, Inc. · Form D, Jul 24, 2026
Madhu Ayyagari
CEO and director
Hirak Parikh
Director
RL
Richel Liu
Director
David Acker
Secretary and director
CSA Medical, Inc. · Form D, Jul 23, 2026
WM
Wendelin Maners
President and CEO, director
SC
Sean Cheng
Director
PL
Paul LaViolette
Director
VO
Vincent Owens
Executive officer and director
TD
Tracy Marshbanks, Ph.D.
Director
LD
Luc Marengere, Ph.D.
Managing Partner and director